论文部分内容阅读
目的探讨脑血管支架置入对脑梗死的预防作用,为脑梗死的临床预防提供参考依据。方法共纳入54例脑梗死患者,按照患者及家属是否接受脑血管支架置入手术的意愿分为A、B两组,A组给予脑血管支架置入治疗措施;B组给予常规内科治疗措施。随访6个月,观察两组患者脑梗死复发情况,并进行NIHSS评分评价。结果两组患者NIHSS评分比较结果显示:两组患者术前NIHSS评分比较差异无统计学意义(P﹥0.05);术后两组患者NIHSS评分均明显下降,但与B组(常规内科治疗)相比,A组(脑血管支架置入)下降更明显,差异有统计学意义(P﹤0.05)。术后两组患者脑梗死再发比较结果显示:术后1个月,两组患者均未有脑梗死发作;术后3个月B组(常规内科治疗)患者有1例再发脑梗死;术后6个月,B组(常规内科治疗)患者共有2例再发脑梗死,而A组(脑血管支架置入)未有再发脑梗死发生。结论脑血管支架置入治疗不仅可以明显改善脑梗死患者的症状,且可以明显降低患者再次发生脑梗死的风险,对脑梗死患者再发有明显的预防作用,值得临床推广应用。
Objective To investigate the preventive effect of cerebral vascular stenting on cerebral infarction and provide a reference for clinical prevention of cerebral infarction. Methods A total of 54 patients with cerebral infarction were enrolled in this study. Patients were divided into two groups according to their willingness to accept cerebrovascular stent implantation. Group A received cerebrovascular stent treatment and group B received conventional medical treatment. Followed up for 6 months, observed the recurrence of cerebral infarction in both groups and evaluated the NIHSS score. Results The NIHSS score of the two groups showed that there was no significant difference in preoperative NIHSS scores between the two groups (P> 0.05). NIHSS scores of the two groups were significantly decreased after operation, but not significantly different from those of group B (conventional medical treatment) Compared with group A, the decrease of cerebrovascular stents was more significant, the difference was statistically significant (P <0.05). Comparisons of cerebral infarction recurrence between the two groups showed that no cerebral infarction was found in both groups at 1 month after surgery. One case of recurrent cerebral infarction was observed in group B (conventional medical treatment) at 3 months after operation. Six months after operation, there were 2 cases of recurrent cerebral infarction in group B (routine medical treatment), and no recurrence of cerebral infarction in group A (cerebrovascular stent implantation). Conclusion Cerebrovascular stent implantation can not only significantly improve the symptoms of patients with cerebral infarction, but also significantly reduce the risk of recurrent cerebral infarction in patients with recurrent cerebral infarction have significant preventive effect, it is worth promoting the clinical application.